Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Clinical trial NCT00833248 · COMPLETED

Trial details

NCT number: NCT00833248
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2009-04-01
Primary completion: 2011-09-01
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.